Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.28%
Insider Ownership
14.78%
Institutional Own.
37.13%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
MET642 Details Ulcerative colitis | Failed Discontinued | |
MET409 Details Non-alcoholic steatohepatitis , Liver disease | Failed Discontinued |